Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monte Rosa Therapeutics

6.06
+0.21003.59%
Post-market: 6.060.00000.00%16:13 EST
Volume:831.79K
Turnover:4.98M
Market Cap:372.30M
PE:-3.43
High:6.14
Open:5.79
Low:5.73
Close:5.85
Loading ...

Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

GlobeNewswire
·
24 Feb

Conviction stock-picking drives biotech success: a biotech market review of 2024

LiveWire
·
17 Jan

Monte Rosa Therapeutics Outlines 2025 Milestones and Financial Strength

TIPRANKS
·
10 Jan

Monte Rosa Therapeutics provide corporate update, key milestones 2025

TIPRANKS
·
10 Jan

Monte Rosa Therapeutics Inc: Biomarker and Activity Data, From Mrt-2359 Phase 1/2 Study Expected in Q1 2025

THOMSON REUTERS
·
10 Jan

Monte Rosa Therapeutics: Mrt-8102, a Nek7-Directed Mgd Targeting Diseases Driven by Il-1Β & Nlrp3 Inflammasome, on Track for Ind Filing in H1 2025

THOMSON REUTERS
·
10 Jan

Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025

THOMSON REUTERS
·
10 Jan

Monte Rosa Therapeutics: Year-End Cash & Equivalents Expected to Be $377 Mln as of Dec 31, 2024 and Anticipated to Fund Ops Into 2028

THOMSON REUTERS
·
10 Jan

Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025

GlobeNewswire
·
10 Jan

Monte Rosa Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
06 Jan

Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term

Zacks
·
23 Dec 2024

Wells Fargo Downgrades Monte Rosa Therapeutics to Equalweight From Overweight, Cuts Price Target to $11 From $14

MT Newswires Live
·
19 Dec 2024

Monte Rosa Therapeutics Appoints DR. Eric a. Hughes to Board of Directors

THOMSON REUTERS
·
13 Dec 2024

Press Release: Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors

Dow Jones
·
13 Dec 2024

Monte Rosa Therapeutics Preclinical Trial of Potential Breast Cancer Therapy Shows Less Toxicity, Tumor Regression

MT Newswires Live
·
11 Dec 2024

Monte Rosa Closes Global License Agreement With Novartis

MT Newswires Live
·
11 Dec 2024